Cited by 283Ovarian function and disordersMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling

Corbould, Anne, Kim, Young-Bum, Youngren, Jack F., Pender, Celia, Kahn, Barbara B., Lee, Anna, Dunaif, Andrea·2005·American Journal of Physiology-Endocrinology and Metabolism

DOI 10.1152/ajpendo.00361.2004

Open this paper in CoChat — free account

Abstract

Insulin resistance in polycystic ovary syndrome (PCOS) is due to a postbinding defect in signaling that persists in cultured skin fibroblasts and is associated with constitutive serine phosphorylation of the insulin receptor (IR). Cultured skeletal muscle from obese women with PCOS and age- and body mass index-matched control women ( n = 10/group) was studied to determine whether signaling defects observed in this tissue in vivo were intrinsic or acquired. Basal and insulin-stimulated glucose transport and GLUT1 abundance were significantly increased in cultured myotubes from women with PCOS. Neither IR β-subunit abundance and tyrosine autophosphorylation nor insulin receptor substrate (IRS)-1-associated phosphatidylinositol (PI) 3-kinase activity differed in the two groups. However, IRS-1 protein abundance was significantly increased in PCOS, resulting in significantly decreased PI 3-kinase activity when normalized for IRS-1. Phosphorylation of IRS-1 on Ser 312 , a key regulatory site, was significantly increased in PCOS, which may have contributed to this signaling defect. Insulin signaling via IRS-2 was also decreased in myotubes from women with PCOS. In summary, decreased insulin-stimulated glucose uptake in PCOS skeletal muscle in vivo is an acquired defect. Nevertheless, there are intrinsic abnormalities in glucose transport and insulin signaling in myotubes from affected women, including increased phosphorylation of IRS-1 Ser 312 , that may confer increased susceptibility to insulin resistance-inducing factors in the in vivo environment. These abnormalities differ from those reported in other insulin resistant states consistent with the hypothesis that PCOS is a genetically unique disorder conferring an increased risk for type 2 diabetes.

Integrity signals

Registry

Crossref · 10.1152/ajpendo.00361.2004

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
Self-citation
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Self-citation
Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O. D., Kim, J. K., Kim, Y., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,276
Self-citation
Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257 · cited 9×
“None of the subjects had T2DM.”
BackgroundInfluential
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139
Prevention of fat-induced insulin resistance by salicylate
Kim, J. K., Kim, Y.-J., Fillmore, J. J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. W., Karin, M., Perret, P., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11559 · Cited by 737
Self-citation

Show all 57 references

Sorted by citations

Items 101–200 of 282

Genomic variants in polycystic ovary syndrome
Luque‐Ramírez, M., Millán, J. L. S., & Escobar-Morreale, H. F. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.017 · Cited by 48
Inflammation in Response to Glucose Ingestion Is Independent of Excess Abdominal Adiposity in Normal-Weight Women with Polycystic Ovary Syndrome
González, F., Sia, C. L., Shepard, M. K., Rote, N. S., & Minium, J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2131 · Cited by 46
Prenatal androgen excess programs metabolic derangements in pubertal female rats
Yan, X., Dai, X., Wang, J., Zhao, N., Cui, Y., & Liu, J. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0577 · Cited by 46
Evidence-based hormonal, mutational, and endocrine-disrupting chemical-induced zebrafish as an alternative model to study PCOS condition similar to mammalian PCOS model
Sudhakaran, G., Guru, A., Haridevamuthu, B., Murugan, R., Arshad, A., & Arockiaraj, J. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120276 · Cited by 47
Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross—Sectional study
Hasan, M., Sultana, S., Sohan, M., Parvin, S., Rahman, M. A., Hossain, M. J., Rahman, M. S., & Islam, M. R. (2022) · PLOS ONE · doi:10.1371/journal.pone.0270102 · Cited by 45
Endothelial Function Varies According to Insulin Resistance Disease Type
Beckman, J. A., Goldfine, A. B., Dunaif, A. E., Gerhard‐Herman, M. D., & Creager, M. A. (2007) · Diabetes Care · doi:10.2337/dc06-2142 · Cited by 42
Self-citation
Identification of Polycystic Ovary Syndrome (PCOS) Specific Genes in Cumulus and Mural Granulosa Cells
Aydos, A., Gurel, A., Islakoğlu, Y. Ö., Noyan, S., Gokce, B., Ecemiş, T., Kaya, C., Aksu, A. T., & Dedeoğlu, B. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168875 · Cited by 41
Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome
Xu, Q., Zhang, J., Lu, Y., & Wu, L. Y. (2024) · iScience · doi:10.1016/j.isci.2024.108783 · Cited by 43
The roles of MAPK signaling pathway in ovarian folliculogenesis
Zhao, H. L., Trang, D., Wang, Y., & Yang, Y. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01737-9 · Cited by 47
The use and misuse of matching in case-control studies: the example of polycystic ovary syndrome
Bloom, M. S., Schisterman, E. F., & Hediger, M. L. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.125 · Cited by 40
When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
Franks, S. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03934.x · Cited by 39
From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management
Pani, A., Gironi, I., Di Vieste, G., Mion, E., Bertuzzi, F., & Pintaudi, B. (2020) · International Journal of Endocrinology · doi:10.1155/2020/6276187 · Cited by 38
The insulin-resistant phenotype of polycystic ovary syndrome
Svendsen, P. F., Madsbad, S., & Nilas, L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.008 · Cited by 38
Vitamin D3 affects mitochondrial biogenesis through mitogen‐activated protein kinase in polycystic ovary syndrome mouse model
Safaei, Z., Bakhshalizadeh, S., Nasr‐Esfahani, M. H., Sene, A. A., Najafzadeh, V., Soleimani, M., & Shirazi, R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29540 · Cited by 39
Transcriptomic Profile of New Gene Markers Encoding Proteins Responsible for Structure of Porcine Ovarian Granulosa Cells
Kulus, J., Kulus, M., Kranc, W., Jopek, K., Zdun, M., Józkowiak, M., Jaśkowski, J. M., Piotrowska‐Kempisty, H., Bukowska, D., Antosik, P., et al. (2021) · Biology · doi:10.3390/biology10111214 · Cited by 37
Impaired Insulin Activation and Dephosphorylation of Glycogen Synthase in Skeletal Muscle of Women with Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
Glintborg, D., Højlund, K., Andersen, N. R., Hansen, B. F., Beck‐Nielsen, H., & Wojtaszewski, J. F. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0760 · Cited by 37
Exercise-induced anti-inflammatory effects in overweight/obese women with polycystic ovary syndrome
Dantas, W. S., das Neves, W., Gil, S. D. S., Barcellos, C. R. G., Rocha, M. P., de Sá‐Pinto, A. L., Roschel, H., & Gualano, B. (2019) · Cytokine · doi:10.1016/j.cyto.2019.04.006 · Cited by 35
Correlation between Expression of Glucose Transporters in Granulosa Cells and Oocyte Quality in Women with Polycystic Ovary Syndrome
Kim, E., Seok, H. H., Lee, S.-Y., Lee, D. R., Moon, J., Yoon, T. K., Lee, W. S., & Lee, K. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.1.40 · Cited by 36
The altered mononuclear cell-derived cytokine response to glucose ingestion is not regulated by excess adiposity in polycystic ovary syndrome
González, F., Sia, C. L., Shepard, M. K., Rote, N. S., & Minium, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2046 · Cited by 35
Targeting insulin sensitivity in the treatment of polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903190699 · Cited by 35
Polycystic ovary syndrome in adolescents
Dabadghao, P. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.04.006 · Cited by 38
Prenatal Steroids and Metabolic Dysfunction: Lessons from Sheep
Cardoso, R. C., & Padmanabhan, V. (2018) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-020518-115154 · Cited by 34
Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming
Leung, K. L., Sanchita, S., Pham, C. T., Davis, B. A., Okhovat, M., Ding, X., Dumesic, P., Grogan, T. R., Williams, K. J., Morselli, M., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00970-x · Cited by 33
Angptl7 promotes insulin resistance and type 2 diabetes mellitus by multiple mechanisms including SOCS3‐mediated IRS1 degradation
Xu, T., Xu, L., Meng, P., Ma, X., Yang, X., Zhou, Y., & Feng, M. (2020) · The FASEB Journal · doi:10.1096/fj.202000246rr · Cited by 32
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
Mason, H. D., Colao, A., Blume‐Peytavi, U., Rice, S., Qureshi, A., Pellatt, L. J., Orio, F., & Atkin, S. L. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03329.x · Cited by 33
A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
Legro, R. S. (2007) · JAMA · doi:10.1001/jama.297.5.509 · Cited by 33
The effect of genistein on insulin resistance, inflammatory factors, lipid profile, and histopathologic indices in rats with polycystic ovary syndrome
Amanat, S., Ashkar, F., Eftekhari, M. H., Tanideh, N., Doaei, S., Gholamalizadeh, M., Koohpeyma, F., & Mokhtari, M. (2021) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2020.04231 · Cited by 31
Insulin Resistance in PCOS
Diamanti‐Kandarakis, E., & Christakou, C. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_4 · Cited by 32
Liraglutide mends cognitive impairment by averting Notch signaling pathway overexpression in a rat model of polycystic ovary syndrome
Saad, M. A., Eltarzy, M. A., Abdelsalam, R. M., & Ahmed, M. A. E. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118731 · Cited by 30
Insulin-Mediated Substrate Use in Women With Different Phenotypes of PCOS: the Role of Androgens
Tosi, F., Villani, M., Migazzi, M., Faccin, G., Garofalo, S., Fiers, T., Kaufman, J., Bonora, E., & Moghetti, P. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab380 · Cited by 31
Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
Wongwananuruk, T., Rattanachaiyanont, M., Indhavivadhana, S., Leerasiri, P., Techatraisak, K., Tanmahasamut, P., Angsuwathana, S., & Dangrat, C. (2012) · International Journal of Endocrinology · doi:10.1155/2012/529184 · Cited by 30
Influence of Phenotypes on the Metabolic Syndrome of Women with Polycystic Ovary Syndrome over a Six-Year Follow-Up in Brazil
Soares, J. M., Hayashida, S. A. Y., Marcondes, J. A. M., Maciel, G. A. R., Barcellos, C. R. G., Maffazioli, G. D. N., Monteiro, K. K. A. C., Turri, J. A. O., Azziz, R., & Baracat, E. C. (2023) · Biomedicines · doi:10.3390/biomedicines11123262 · Cited by 29
Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study
Kazemi, M., Jarrett, B. Y., Parry, S. A., Thalacker‐Mercer, A. E., Hoeger, K. M., Spandorfer, S. D., & Lujan, M. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa426 · Cited by 29
The effect of metformin treatment in vivo on acute and long-term energy metabolism and progesterone production in vitro by granulosa cells from women with polycystic ovary syndrome
Maruthini, D., Harris, S. E., Barth, J. H., Balen, A. H., Campbell, B. K., & Picton, H. M. (2014) · Human Reproduction · doi:10.1093/humrep/deu187 · Cited by 29
Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome
Wang, D., & He, B. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s362424 · Cited by 28
Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS
Eriksen, M. B., Pørneki, A. D., Skov, V., Burns, J. S., Beck‐Nielsen, H., Glintborg, D., & Gaster, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014469 · Cited by 29
Levels of Rabs and WAVE family proteins associated with translocation of GLUT4 to the cell surface in endometria from hyperinsulinemic PCOS women
Rosas, C., Gabler, F., Vantman, D., Romero, C., & Vega, M. (2010) · Human Reproduction · doi:10.1093/humrep/deq232 · Cited by 26
Pigment Epithelium‐Derived Factor, Insulin Sensitivity, and Adiposity in Polycystic Ovary Syndrome: Impact of Exercise Training
Joham, A. E., Teede, H. J., Hutchison, S. K., Stepto, N. K., Harrison, C. L., Strauss, B. J., Paul, E. M., & Watt, M. J. (2012) · Obesity · doi:10.1038/oby.2012.135 · Cited by 26
Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
Liu, Z., Wang, R., & Wang, K. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01092-x · Cited by 30
Dynamic Change in Insulin Resistance Induced by Free Fatty Acids Is Unchanged Though Insulin Sensitivity Improves Following Endurance Exercise in PCOS
Aye, M. M., Butler, A. E., Kilpatrick, E. S., Kirk, R., Vince, R. V., Rigby, A. S., Sandeman, D. D., & Atkin, S. L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00592 · Cited by 25
Insulin Resistance and Polycystic ovary Syndrome: A Review
Maqbool, M., Dar, M. A., Gani, I., & Geer, M. I. (2019) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v9i1-s.2275 · Cited by 25
Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive‐aged women with polycystic ovary syndrome: A systematic review and meta‐analysis of 45 observational studies
Kazemi, M., Pierson, R. A., Parry, S. A., Kaviani, M., & Chilibeck, P. D. (2021) · Obesity Reviews · doi:10.1111/obr.13255 · Cited by 24
Molecular Mechanisms in the Etiology of Polycystic Ovary Syndrome (PCOS): A Multifaceted Hypothesis Towards the Disease with Potential Therapeutics
Nisa, K. U., Tarfeen, N., Mir, S. A., Waza, A. A., Ahmad, M. B., & Ganai, B. A. (2023) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-023-01130-7 · Cited by 28
Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model
Xiong, T., Paris, V. R., Edwards, M. C., Hu, Y., Cochran, B. J., Rye, K., Ledger, W. J., Padmanabhan, V., Handelsman, D. J., Gilchrist, R. B., et al. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00418.2021 · Cited by 22
Progressive Resistance Training in Polycystic Ovary Syndrome: Can Pumping Iron Improve Clinical Outcomes?
Cheema, B. S., Vizza, L., & Swaraj, S. (2014) · Sports Medicine · doi:10.1007/s40279-014-0206-6 · Cited by 25
Insulin-induced capillary recruitment is impaired in both lean and obese women with PCOS
Ketel, I. J. G., Serné, E. H., IJzerman, R. G., Korsen, T. J. M., Twisk, J. W. R., Hompes, P. G. A., Smulders, Y. M., Homburg, R., Vorstermans, L., Stehouwer, C. D. A., et al. (2011) · Human Reproduction · doi:10.1093/humrep/der296 · Cited by 23
Bitter Taste Receptor Ligand Improves Metabolic and Reproductive Functions in a Murine Model of PCOS
Wu, S., Xue, P., Grayson, N., Bland, J. S., & Wolfe, A. (2018) · Endocrinology · doi:10.1210/en.2018-00711 · Cited by 22
The Pro12Ala polymorphism of the PPAR-γ gene is not associated with the polycystic ovary syndrome
Xita, N. V., Lazaros, L. A., Georgiou, I. A., & Tsatsoulis, A. A. (2009) · HORMONES · doi:10.1007/bf03401274 · Cited by 22
Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome
Huang‐Doran, I., & Franks, S. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00053 · Cited by 23
SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19
Huffman, A. M., Rezq, S., Basnet, J., Cardozo, L. L. Y., & Romero, D. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094472 · Cited by 26
Testosterone treatment increases androgen receptor and aromatase gene expression in myotubes from patients with PCOS and controls, but does not induce insulin resistance
Eriksen, M. B., Glintborg, D., Nielsen, M. F. B., Jakobsen, M. A., Brusgaard, K., Tan, Q., & Gaster, M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.033 · Cited by 22
Prevalence and predictors of risk for type 2 diabetes mellitus andimpaired glucose tolerance in polycystic ovary syndrome
Shamdeen, M. Y., & Saber, M. (2005) · TSpace (University of Toronto) · Cited by 22
Increased Skeletal Muscle Fiber Cross-Sectional Area, Muscle Phenotype Shift, and Altered Insulin Signaling in Rat Hindlimb Muscles in a Prenatally Androgenized Rat Model for Polycystic Ovary Syndrome
DeChick, A., Hetz, R., Lee, J., & Speelman, D. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217918 · Cited by 21
Transforming Growth Factor Beta 1 Alters Glucose Uptake but Not Insulin Signalling in Human Primary Myotubes From Women With and Without Polycystic Ovary Syndrome
McIlvenna, L. C., Patten, R. K., McAinch, A. J., Rodgers, R. J., Stepto, N. K., & Moreno‐Asso, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.732338 · Cited by 19
Body weight reduction and metformin: Roles in polycystic ovary syndrome
AL-Nozha, O., Habib, F., Mojaddidi, M., & El-Bab, M. F. (2013) · Pathophysiology · doi:10.1016/j.pathophys.2013.03.002 · Cited by 20
Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome
Dumesic, D. A., Winnett, C., Lu, G., Grogan, T., Abbott, D. H., Naik, R., & Chazenbalk, G. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.09.324 · Cited by 20
Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome
Connolly, A., Leblanc, S., & Baillargeon, J. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4315413 · Cited by 19
Effects of metformin on body weight in polycystic ovary syndrome patients: model-based meta-analysis
Chen, X., He, S., & Wang, D. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1863788 · Cited by 20
Metabolic Disturbance in PCOS: Clinical and Molecular Effects on Skeletal Muscle Tissue
Dantas, W. S., Gualano, B., Rocha, M. P., Barcellos, C. R. G., Yance, V. D. R. V., & Marcondes, J. A. M. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/178364 · Cited by 22
Lean mass and associated factors in women with PCOS with different phenotypes
Fighera, T. M., dos Santos, B. R., & Spritzer, P. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292623 · Cited by 19
Polycystic ovary syndrome in adolescence
Bruni, V., Dei, M., Nannini, S., Balzi, D., & Nuvolone, D. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05648.x · Cited by 19
Relationship between Serum Levels of Anti-Mullerian Hormone, Adiponectin and Oxidative Stress Markers in Patients with Polycystic Ovary Syndrome.
Kohzadi, M., Khazaei, M. R., Chobsaz, F., & Khazaei, M. (2020) · Europe PMC (PubMed Central) · doi:10.22074/ijfs.2020.5809 · Cited by 18
Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome
Elkind-Hirsch, K. E. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605030-00005 · Cited by 18
Potent therapeutic effects of Shouwu Jiangqi Decoction (首乌僵芪汤) on polycystic ovary syndrome with insulin resistance in rats
Wang, L., Wang, X., Yu, X., & Xu, W. (2015) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-015-2147-9 · Cited by 17
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: the impact of androgen excess on metabolic health
Cussen, L., McDonnell, T., Miller, C., McIlroy, M., & O’Reilly, M. (2025) · Reproduction · doi:10.1530/rep-25-0102 · Cited by 19
Key signalling pathways underlying the aetiology of polycystic ovary syndrome
Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19
Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes
Zhou, W., Hong, Y., Yin, A., Liu, S., Chen, M., Lv, X., Nie, X., Tan, N., & Zhang, Z. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113262 · Cited by 16
Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome
Scott, D. S., Joham, A. E., Teede, H. J., Gibson‐Helm, M. E., Harrison, C. L., Cassar, S., Hutchison, S. K., Ebeling, P. R., Stepto, N. K., & de Courten, B. V. (2016) · Nutrients · doi:10.3390/nu8120774 · Cited by 16
Comparative analysis of fennel essential oil and manganese in PCOS rat model via modulating miR-145 expression and structure-based virtual screening of IGF2R protein to address insulin resistance and obesity
Barancheshmeh, M., Najafzadehvarzi, H., Shokrzadeh, N., & Aram, C. (2024) · Obesity Medicine · doi:10.1016/j.obmed.2024.100574 · Cited by 15
Female-Specific Factors for IHD: Across the Reproductive Lifespan
SHUFELT, C. L., Waldman, T., Wang, E. T., & Merz, C. N. B. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0481-6 · Cited by 15
Dihydrotestosterone deteriorates cardiac insulin signaling and glucose transport in the rat model of polycystic ovary syndrome
Tepavčević, S., Milutinović, D. V., Μacut, D., Žakula, Z., Nikolič, M., Antić, I. B., Romić, S., Bjekić-Macut, J., Matić, G. M., & Korićanac, G. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.01.006 · Cited by 15
Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome
EL-Mesallamy, H. O., El-Razek, R. S. A., & El‐Refaie, T. A. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.01.015 · Cited by 15
Non-cell autonomous mechanisms control mitochondrial gene dysregulation in polycystic ovary syndrome
Moreno‐Asso, A., Altıntaş, A., McIlvenna, L. C., Patten, R. K., Botella, J., McAinch, A. J., Rodgers, R. J., Barrès, R., & Stepto, N. K. (2021) · Journal of Molecular Endocrinology · doi:10.1530/jme-21-0212 · Cited by 15
Proteomic analysis shows decreased type I fibers and ectopic fat accumulation in skeletal muscle from women with PCOS
Stener‐Victorin, E., Eriksson, G., Shrestha, M. M., Paris, V. R., Lu, H., Banks, J. L., Samad, M., Perian, C., Jude, B., Engman, V., et al. (2023) · eLife · doi:10.7554/elife.87592 · Cited by 20
Cultural Experiences, Patterns, and Practices of American Indian Women With Polycystic Ovary Syndrome: An Ethnonursing Study
Carron, R., Kooienga, S., Gilman-Kehrer, E., & Alvero, R. J. (2019) · Journal of Transcultural Nursing · doi:10.1177/1043659619856670 · Cited by 14
Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome
Rissanen, A., Koskela-Koivisto, T., Hägglund, H., Koponen, A. S., Aho, J. M., Pöyhönen‐Alho, M., Tiitinen, A. E., Tikkanen, H. O., & Peltonen, J. E. (2016) · Physiological Reports · doi:10.14814/phy2.12719 · Cited by 14
MAPK and ERK polymorphisms are associated with PCOS risk in Chinese women
Hu, L., Zhang, Y., Chen, L., Zhou, W., Wang, Y., & Wen, J. (2017) · Oncotarget · doi:10.18632/oncotarget.22153 · Cited by 15
FEM1A is a candidate gene for polycystic ovary syndrome
Maher, J., Hines, R. S., Futterweit, W., Crawford, S., Lu, D., Shen, P., Oefner, P. J., Kazi, M. H., Wilson, J. G., Subauste, J. S., et al. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500431458 · Cited by 13
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
McDonnell, T., Cussen, L., McIlroy, M., & O’Reilly, M. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221113140 · Cited by 15
Polycystic Ovary Syndrome and Eating Disorders—A Literature Review
Góral, A., Żywot, K., Zalewski, W., Jagodziński, A., & Murawski, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm14010027 · Cited by 14
Molecular Mechanisms of Insulin Resistance in the Polycystic Ovary Syndrome
Ciaraldi, T. P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_26 · Cited by 12
Genetic polymorphisms associated with polycystic ovary syndrome among Iranian women
Jamshidi, M., Pour, S. M., Bahadoram, M., Mahmoudian‐Sani, M., & Saeedi‐Boroujeni, A. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13534 · Cited by 12
Insulin Receptor Substrate 1 Gly972Arg (rs1801278) Polymorphism Is Associated with Obesity and Insulin Resistance in Kashmiri Women with Polycystic Ovary Syndrome
Rasool, S. U. A., Nabi, M., Ashraf, S., & Amin, S. (2022) · Genes · doi:10.3390/genes13081463 · Cited by 11
Improving Rural Nurse Practitioner Knowledge About Polycystic Ovary Syndrome Through Continuing Education
Carron, R., Simon, N., Gilman-Kehrer, E., & Boyle, D. K. (2018) · The Journal of Continuing Education in Nursing · doi:10.3928/00220124-20180320-06 · Cited by 11
The Insulin Resistance of Polycystic Ovary Syndrome
Demissie, M., Legro, R. S., & Dunaif, A. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_26 · Cited by 11
Self-citation
White-brown adipose tissue interplay in polycystic ovary syndrome: Therapeutic avenues
Abbasi, K., Zarezadeh, R., Valizadeh, A., Mehdizadeh, A., Hamishehkar, H., Nouri, M., & Darabi, M. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.116012 · Cited by 12
Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome
González, F., Kirwan, J. P., Rote, N. S., & Minium, J. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.06.044 · Cited by 10
Prevalence of the insulin receptor substrate-1(IRS-1) Gly972Arg and the insulin receptor substrate-2(IRS-2) Gly1057Asp polymorphisms in PCOS patients and non-diabetic healthy women
Rashidi, B. H., Azizy, L., Najmeddin, F., & Azizi, E. (2011) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-011-9693-7 · Cited by 10
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: an evolutionary metabolic adaptation
Dumesic, D. A., Padmanabhan, V., & Abbott, D. H. (2025) · Reproduction · doi:10.1530/rep-25-0021 · Cited by 11
On the Intimate Relationship of Adiposity to Polycystic Ovary Syndrome
Rosenfield, R. L., & Dumesic, D. A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf527 · Cited by 11
VNTR I/I genotype of insulin gene is associated with the increase of follicle number independent from polycystic ovary syndrome
Haller, K., Laisk, T., Peters, M., Talving, E., Karits, P., Karro, H., Uibo, R., & Salumets, A. (2007) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340701322085 · Cited by 9
Insulin Resistance in Polycystic Ovary Syndrome
Sung, Y. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.1.1 · Cited by 8
Selective impairment in glycogen synthase kinase-3 and mitogen-activated protein kinase phosphorylation: comparisons with the hyperandrogenic and the hyperinsulinemic rats
Chen, Y., Qiao, J., Yan, L., Huang, S., Zhao, P.-L., & Yan, J. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.073 · Cited by 9
Progranulin and tumor necrosis factor-alpha in lean polycystic ovary syndrome patients
Uzdoğan, A., Pekcan, M. K., Çil, A. P., Kısa, Ü., & Akbıyık, F. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1958311 · Cited by 8
Cardiometabolic Risk, Peripheral Arterial Disease and Cardiovascular Events in Polycystic Ovary Syndrome: Time to Implement Systematic Screening and Update the Management
Janež, A., Herman, R., Poredoš, P., Mikhailidis, D. P., Blinc, A., Šabović, M., Studen, K. B., Jezovnik, M. K., Schernthaner, G.-H., Anagnostis, P. G., et al. (2023) · Current Vascular Pharmacology · doi:10.2174/0115701611269146230920073301 · Cited by 10
Phosphatidylinositol 3-kinase p85 regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome
Kim, J., Choi, Y. M., Hong, M. A., Hwang, S.-S., Yoon, S. H., Chae, S. J., Jee, B. C., Ku, S., Kim, J. G., & Moon, S. Y. (2009) · Human Reproduction · doi:10.1093/humrep/dep019 · Cited by 7
Effect of vitamin D on experimental model of polycystic ovary syndrome in female rats
Helal, B. A. E., Ismail, G. M., Nassar, S., & Zeid, A. A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119558 · Cited by 7
Obesity, Metabolic Dysfunction, and Inflammation in Polycystic Ovary Syndrome
Aubuchon, M., Bickhaus, J. A., & González, F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_8 · Cited by 7
Tenascin C activates the toll‑like receptor 4/NF‑κB signaling pathway to promote the development of polycystic ovary syndrome
Wu, H., Yang, M., Yan, C., Liu, M., Wang, H., & Zhang, W. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13230 · Cited by 6
Pathophysiology of polycystic ovary syndrome
Raja, M. H. R., Javed, M. A., & Rehman, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00013-x · Cited by 6

Authors: Corbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A.
Affiliations: Brigham and Women's Hospital (US)
Harvard University (US)
University of California, San Francisco (US)
ORCID: Kim, Young-Bum
Youngren, Jack F.
Kahn, Barbara B.
Lee, Anna
Dunaif, Andrea
Venue: American Journal of Physiology-Endocrinology and Metabolism
Publisher: American Physiological Society
Published: 2005-05
Volume: 288
Issue: 5
Pages: E1047-E1054
ISSN: 0193-1849 (ISSN-L)
1522-1555
DOI: 10.1152/ajpendo.00361.2004
OpenAlex: W2152304127
Cited by: 283
References: 57
Citations by year: 2026: 11 · 2025: 14 · 2024: 10 · 2023: 18 · 2022: 15 · 2021: 17 · 2020: 22 · 2019: 11 · 2018: 10 · 2017: 5 · 2016: 11 · 2015: 12 · 2014: 14 · 2013: 11 · 2012: 14
FWCI: 12.34
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, R01 DK43051, R01DK040605, P30DK57521, R01 DK-40605, R01DK043051)
National Center for Research Resources (RR02635, M01RR002635)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54-HD34449, U54HD034449)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: polycystic ovary syndrome, insulin resistance, skeletal muscle, insulin signaling, insulin receptor, insulin receptor substrate 2, PI3-kinase, glucose transport, GLUT1, myotubes, type 2 diabetes risk
MeSH terms: Adult, Cells, Cultured, Female, Glucose, Humans, Insulin, Insulin Resistance, Polycystic Ovary Syndrome, Receptor, Insulin, Signal Transduction, Muscle, Skeletal, Muscle Fibers, Skeletal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks